Research Paper Volume 13, Issue 11 pp 15433—15443
Galectin-3/adiponectin as a new biological indicator for assessing the risk of type 2 diabetes: a cross-sectional study in a community population
Figure 1. Distribution of diabetes in total population, Group I or Group II stratified by quartiles of biomarkers. (A–C) Adiponectin, (D–F) Galectin-3; (G–I) Galectin-3/adiponectin. Group I: population with the age< 50 years old; Group II: population with the age≥50 years old.